Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Moussab Damlaj; Ahmed Alaskar; Bader Alahmari; Samer Ghazi; Ayman Hejazi; Mohsen Alzahrani

doi:10.1016/j.clml.2018.07.115

$Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma$

Journal article

Peer reviewed

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Moussab Damlaj, Ahmed Alaskar, Bader Alahmari, Samer Ghazi, Ayman Hejazi and Mohsen Alzahrani

Clinical lymphoma, myeloma and leukemia, Vol.18, p.S233

09/2018

DOI: https://doi.org/10.1016/j.clml.2018.07.115

Metrics

1 Record Views

Details

Title: Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma
Creators - without role: Moussab Damlaj - King Abdulaziz Medical City
Ahmed Alaskar - King Saud bin Abdulaziz University for Health Sciences
Bader Alahmari - King Abdulaziz Medical City
Samer Ghazi - King Abdulaziz Medical City
Ayman Hejazi - King Saud bin Abdulaziz University for Health Sciences
Mohsen Alzahrani - King Abdulaziz Medical City
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.18, p.S233
Identifiers: 9920960808331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences; King Saud University
Language: English
Resource Type: Journal article